コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 tients referred to Oslo University Hospital (tertiary referral center).
2 a cross-sectional study at a single academic tertiary referral center.
3 ndergoing cranial and spinal operations in a tertiary referral center.
4 ith history of microbial keratitis seen at a tertiary referral center.
5 e consecutive case series was conducted at a tertiary referral center.
6 for 19 children with cataract operated at a tertiary referral center.
7 ed cirrhosis, confirmed by histology, from a tertiary referral center.
8 in a hypertrophic cardiomyopathy cohort at a tertiary referral center.
9 The authors are from a pediatric tertiary referral center.
10 r inflammatory disease in a university-based tertiary referral center.
11 were diagnosed with posterior scleritis in a tertiary referral center.
12 raction maculopathy by a single surgeon at a tertiary referral center.
13 roidectomy and routine prophylactic CND at a tertiary referral center.
14 period (January 1999 to December 2000) at a tertiary referral center.
15 ypertrophic cardiomyopathy (HCM) seen at our tertiary referral center.
16 th 82 VCFs who underwent vertebroplasty at a tertiary referral center.
17 ween 1996 and 2001 who were followed up in a tertiary referral center.
18 98 lesions in 7147 consecutive patients at a tertiary referral center.
19 from a multidisciplinary dyspnea clinic at a tertiary referral center.
20 went percutaneous coronary intervention in a tertiary referral center.
21 pective case series at a single institution, tertiary referral center.
22 The study was performed in a tertiary referral center.
23 eated for primary open angle glaucoma in our tertiary referral center.
24 opathologic phenotypes at a university-based tertiary referral center.
25 treated with 35 dexamethasone implants at a tertiary referral center.
26 om August 8, 2006, until June 17, 2015, at a tertiary referral center.
27 at Memorial Sloan-Kettering Cancer Center, a tertiary referral center.
28 rience with MRE in pregnant CD patients in a tertiary referral center.
29 d 2012 with follow-up of 5 to 25 months at a tertiary referral center.
30 May 1, 2010, through October 31, 2012, at a tertiary referral center.
31 e noncomparative analysis was conducted at a tertiary referral center.
32 pectively evaluated by a single surgeon at a tertiary referral center.
33 valuating a new technique was conducted at a tertiary referral center.
34 ugh retrospective medical record review at a tertiary referral center.
35 nterventional case series was conducted at a tertiary referral center.
36 data from 9 patients (11 eyes) with AMN at 6 tertiary referral centers.
37 type 2) the outer plexiform layer (OPL) at 6 tertiary referral centers.
38 nosed with herpes virus infection, seen at 2 tertiary referral centers.
39 l data using current therapeutic regimens at tertiary referral centers.
40 ingly becoming the preferred option at major tertiary referral centers.
41 and increasingly becoming an option at major tertiary referral centers.
42 ts with ALF collected prospectively at 24 US tertiary referral centers.
43 larization for ACS through early transfer to tertiary referral centers.
44 ire specialized care that is offered only at tertiary referral centers.
45 s of up to 6%, based largely on reports from tertiary referral centers.
46 able serum hepatitis B virus DNA in European tertiary referral centers.
47 nts with HCM without prior SCD event, from 2 tertiary referral centers.
48 d February 2015, in neurology departments at tertiary referral centers.
49 ervational multicenter cohort study among MS tertiary referral centers.
50 treated with RFA from 2003 through 2011 at 3 tertiary referral centers.
52 ter registry of patients with BAV treated at tertiary referral centers, 2118 patients with BAV were e
54 cohort of 500 eyes that underwent DMEK at a tertiary referral center, 7 eyes developed typical clini
56 ightly assessments was performed at an urban tertiary referral center and a regional center from Janu
58 h noninfectious anterior scleritis seen at 2 tertiary referral centers and studied the factors associ
60 ul DMEK for Fuchs endothelial dystrophy at a tertiary referral center, best spectacle-corrected visua
61 or 63 eyes of 63 patients who presented to a tertiary referral center between 2006 and 2015 with cult
62 fecal microbiota transplantation (FMT) at a tertiary referral center between 2011 and 2014 to determ
63 ministrative data on 682,704 patients from a tertiary referral center between 2011 and 2015, and iden
64 on (group 2: n = 100) for rectal cancer at a tertiary referral center between December 1998 and July
65 nts undergoing abdominal surgery for CD at a tertiary referral center between January 1998 and June 2
66 derwent radical prostatectomy performed at a tertiary referral center between July 1998 and July 2003
67 ive patients undergoing genetic testing at a tertiary referral center between July 2005 and November
68 patients (n = 641) who underwent OLT at our tertiary referral center between March 1985 and December
69 ervical cancer patients who presented to our tertiary referral center between March 2011 and February
70 ren (aged <21 years) who were evaluated at a tertiary referral center between November 1, 1975, and J
71 Severely ill burn patients admitted to our tertiary referral center between October 2013 and Februa
72 retrospective chart review of patients at a tertiary referral center compares characteristics and cl
75 pective cohort study at an academic hospital tertiary referral center evaluating the growth rate of h
76 largest hospital in the Middle East and the tertiary referral center for all hospitals in Egypt that
78 ort study was conducted using records from a tertiary referral center for autoimmune bullous disorder
79 ules on photodamaged skin was conducted in a tertiary referral center for dermatology between January
80 cutive series of 76 patients presenting to a tertiary referral center for evaluation of chronic progr
81 nd followed up with a family presenting to a tertiary referral center for evaluation of HSP for a dec
82 Only 1% of unrelated individuals seen at a tertiary referral center for HCM possessed one of the fi
83 years sequentially referred to a midwestern tertiary referral center for hearing loss or cochlear im
84 ith CIS between March 2002 and May 2015 in a tertiary referral center for multiple sclerosis, in coll
86 bservational cohort study was conducted at a tertiary referral center for neurological diseases in Ri
87 skeletal and/or eye abnormalities, from a US tertiary referral center for neurological diseases using
88 We queried the medical records of a large tertiary referral center for patients with a history of
89 clinical trial with a 2-year follow-up at a tertiary referral center for pediatric obesity in the Ne
91 012) prospective cohort study conducted in a tertiary referral center for the diagnosis and follow-up
92 a large urban catchment area and serves as a tertiary referral center for the province of Ontario).
94 ction strategies was conducted in 3 European tertiary referral centers for HCM from July 2013 to Dece
95 nrolled patients with PBC (n = 1032) from 23 tertiary referral centers for liver diseases in the Unit
96 rvational study, 2 groups of patients from 2 tertiary referral centers for melanoma (Sydney Melanoma
97 lticenter study was conducted (1992-2010) in tertiary referral centers for treatment of cutaneous mel
98 erve palsies in children, but a study from a tertiary referral center found a high incidence of neopl
99 d subsequently undergoing patch testing at a tertiary referral center from January 1, 2012, through N
100 ing pancreatic surgery at a university-based tertiary referral center from July 1, 2013, through June
102 orders who received ipilimumab at 9 academic tertiary referral centers from January 1, 2012, through
104 istry between October 1985 and May 2014 at a tertiary referral center hosting the Dutch Cutaneous Lym
107 rs of treatment with DFO were recruited in a tertiary referral center in Milan, Italy, and were inves
108 ulfilled the diagnostic criteria for NS in a tertiary referral center in Paris, France, from January
110 pediatric blepharokeratoconjunctivitis at a tertiary referral center in Singapore from 1991 through
112 17 patients 6 years and older at baseline at tertiary referral centers in Europe, the United States,
114 -13 years; 67% male) were identified from 10 tertiary referral centers in the Netherlands and Belgium
115 rospective case series of 21 patients from 5 tertiary referral centers in the United Kingdom and Aust
116 retrospective cohort study was conducted at tertiary referral centers in the United States and Europ
117 l-level primary data were accumulated from 6 tertiary referral centers in the United States, Belgium,
119 nterventional cohort analysis performed at a tertiary referral center included 43 laser-naive patient
120 ed a 1-year randomized controlled trial at a tertiary referral center, including 263 adults (178 with
122 Descriptive, noncomparative case series at a tertiary referral center (Ocular Oncology Service of Wil
125 es from 55 autopsies examined at an academic tertiary referral center over 21 years were tabulated fo
128 rom February 7, 2014, to July 15, 2015, in a tertiary referral center pediatric dermatology clinic an
130 University of Pennsylvania Health System, a tertiary referral center serving a population with a hig
131 omies with additional wedge resections, at a tertiary referral center specialized in laparoscopic hep
132 cava filters on the basis of results from a tertiary referral center specializing in complex filter
134 risk of rupture may be safely undertaken at tertiary referral centers that have expertise in managin
135 The data were obtained from patients from 23 tertiary referral centers throughout the United States a
136 The treatment of pancreatic necrosis at a tertiary referral center was reviewed to effect better p
137 tained from 389 HCM outpatients seen at this tertiary referral center were analyzed for mutations, us
139 dectomy for primary hyperparathyroidism at a tertiary referral center were prospectively given a ques
140 first 100 adult patients treated in a single tertiary referral center were retrospectively identified
143 orts from 1/1/2000 to 12/31/2009 at a single tertiary referral center were reviewed; clinical informa
144 and 85 patients with episcleritis seen at 2 tertiary referral centers were reviewed and their clinic
146 onoverlapping surgical procedures at a large tertiary-referral center where overlapping surgery is pe
147 y a board-certified dermatologist at a large tertiary referral center, where ENFD testing became a ro
148 y a board-certified dermatologist at a large tertiary referral center, where ENFD testing became a ro
149 rly-stage neoplasia should be centralized in tertiary referral centers, where procedures are performe
150 ve review of 263 patients at a large, urban, tertiary referral center who underwent either dynamic pa
151 11, all patients with esophageal cancer in a tertiary referral center, who underwent nCRT (5 weekly c
WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。